TKNO
Alpha Teknova, Inc.
TKNO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
TKNO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
TKNO's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
TKNO PE Valuation
TKNO has no meaningful PE right now: it lost money over the past year.
TKNO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect TKNO's losses to shrink, with revenue growing.
TKNO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.28 | +$0.05 |
| Q2 2026 | -$0.30 | +$0.10 |
| Q1 2026 | -$0.31 | +$0.15 |
| Q4 2025 | -$0.32 | +$0.25 |
| Q3 2025 | -$0.33 | +$0.41 |
| Q2 2025 | -$0.40 | +$0.53 |
| Q1 2025 | -$0.46 | +$0.59 |
| Q4 2024 | -$0.57 | +$0.59 |
TKNO is still losing money, but far less than before: $0.28 per share over the past year, against $1.83 at its worst in mid-2023.
TKNO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $12.7M | +22% |
| Q2 2026 | $12.2M | +18% |
| Q1 2026 | $11.1M | +13% |
| Q4 2025 | $10M | +7.8% |
| Q3 2025 | $10.5M | +9.2% |
| Q2 2025 | $10.3M | +7% |
| Q1 2025 | $9.8M | +5.4% |
| Q4 2024 | $9.3M | +18% |
TKNO's revenue has grown year over year for nine quarters in a row: $13M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -25% | +13 points |
| Q2 2026 | -24% | +9.2 points |
| Q1 2026 | -39% | +12 points |
| Q4 2025 | -46% | +15 points |
| Q3 2025 | -38% | +39 points |
| Q2 2025 | -33% | +20 points |
| Q1 2025 | -51% | +35 points |
| Q4 2024 | -61% | +77 points |
TKNO's operating margin was −25% last quarter, up 13 points from the same quarter a year ago.
TKNO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4M | +$969K |
| Q2 2026 | -$596K | +$1.7M |
| Q1 2026 | -$3.6M | +$729K |
| Q4 2025 | -$810K | +$693K |
| Q3 2025 | -$2.4M | +$23K |
| Q2 2025 | -$2.3M | +$645K |
| Q1 2025 | -$4.3M | +$2.4M |
| Q4 2024 | -$1.5M | +$1.7M |
TKNO has burned cash in almost every quarter: −$6M over the past year, against −$10M the year before.
TKNO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | -47.1x | Net Cash |
| Q1 2021 | -0.5x | Net Cash |
| Q4 2020 | -0.5x | Net Cash |
TKNO has more cash than debt.
TKNO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.0 | Neutral |
| Stochastic | 64.2 | Neutral |
TKNO's weekly RSI is 61 (neutral) and its Stochastic is 64 (neutral).
TKNO PE vs Healthcare Sector
TKNO has no meaningful PE right now: it lost money over the past year.
TKNO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.02 | 3.4% above |
| 20 week MA | $7.02 | 18% above |
| 50 week MA | $4.94 | 68% above |
| 100 week MA | $5.41 | 53% above |
| 200 week MA | $4.43 | 87% above |
TKNO is in an uptrend: it's above all five of its weekly moving averages, and 87% above its 200-week average.
TKNO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $25.0 | $20.4 | -19% |
| 2022 | $20.4 | $5.14 | -75% |
| 2023 | $5.14 | $3.73 | -27% |
| 2024 | $3.73 | $8.73 | +134% |
| 2025 | $8.73 | $4.04 | -54% |
| 2026 YTD | $4.04 | $8.29 | +105% |
TKNO's yearly returns have swung widely, from +134% in 2024 to −75% in 2022. It's up 105% so far in 2026.